Belgium's UCB to buy Ra Pharmaceuticals for US$2.1 billion

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

UCB has agreed to acquire U.S.-based Ra Pharmaceuticals for US$2.1 billion, in a deal that will enable the Belgian drugmaker to offer new ...

UCB has agreed to acquire U.S.-based Ra Pharmaceuticals for US$2.1 billion, in a deal that will enable the Belgian drugmaker to offer new treatment opportunities for several rare diseases in neurology and immunology.

FILE PHOTO: The logo of Belgian drug, chemical, and plastics group UCB is seen at the entrance of the company's headquarters in Brussels March 2, 2010. REUTERS/Yves Herman/File Photo

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US FDA approves Clinuvel Pharma's rare skin disorder treatmentREUTERS: The U.S. Food and Drug Administration on Tuesday approved Australian drugmaker Clinuvel Pharmaceuticals Ltd's treatment for a rare ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AT&T to sell certain assets in Puerto Rico, US Virgin Islands for US$1.95 billionTelecommunications carrier AT&T Inc said on Wednesday it will sell its wireless and wireline operations in Puerto Rico and U.S. Virgin Islands to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Massive jury award against J&J highlights risks of its legal strategyJohnson & Johnson shares were off more than 2per cent on Wednesday, a day after a U.S. jury said it must pay US$8 billion in punitive damages to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Jury says J&J must pay US$8 billion in case over male breast growth linked to RisperdalJohnson & Johnson must pay US$8 billion in punitive damages to a man who previously won US$680,000 over his claims that it failed to warn that ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Jury says J&J must pay US$8 billion in case over male breast growth linked to RisperdalJohnson & Johnson must pay US$8 billion in punitive damages to a man who previously won US$680,000 over his claims that it failed to warn that ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

J&J shares fall but US$8 billion jury award likely to be slashedJohnson & Johnson shares were off more than 2per cent on Wednesday, a day after a U.S. jury said it must pay US$8 billion in punitive damages to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »